Aleksandra Juszczyk-Kalina

Dr. Aleksandra Juszczyk-Kalina


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Postępy Psychiatrii i Neurologii
Verified
Journal Article
Open access
PDF file
AJAleksandra Juszczyk-Kalina
Aleksandra Juszczyk-Kalina
MDMałgorzata Dragan
Małgorzata Dragan
PGPiotr Grajewski
Piotr Grajewski
PHPawel Holas
Pawel Holas
Introduction Due to the current COVID-19 pandemic, many new stressors have arisen, which is associated with an increased risk of mental disorders. The purpose of this article is to assess the prevalence of adjustment disorder and symptoms of anxiety and depression in the Polish...

1 December 2023 in Trials
Verified
Journal Article
Open access
PDF file
AJAleksandra Juszczyk-Kalina
Aleksandra Juszczyk-Kalina
PHP. Holas
P. Holas
TFT. J. Farchione
T. J. Farchione
Background: Adjustment problems and disorders are highly prevalent among university students worldwide. These problems can cause significant interference in academic and social functioning and increase vulnerability to other mental health disorders. Unfortunately, only half of students in need receive psychological help. Furthermore, few studies have evaluated psychological interventions for adjustment disorders in students. New, more scalable forms of treatment for students with an adjustment disorder need to be developed, evaluated, and implemented. The study aims to determine the effectiveness of an online transdiagnostic cognitive behavioural intervention for students experiencing adjustment disorder and to assess mediators of change. Method/design: In this three-arm randomized controlled trial, we plan to recruit 214 Polish students diagnosed with an adjustment disorder. Participants who meet initial eligibility criteria will be randomly assigned to one of three 6-week conditions: (1) online cognitive behavioural therapy intervention based on an existing, empirically supported transdiagnostic protocol, the unified protocol; (2) online progressive muscle relaxation training as an active control group; or (3) waiting-list control group. Both interventions are asynchronous, interactive, and include minimal amount of therapist support. Assessments will consist of self-report questionnaires, daily diary measures, and neurocognitive tasks for evaluating cognitive functioning. These will be conducted at baseline, post-treatment, and 1-month follow-up. Daily diary measures will be taken during the first and last week of treatment (or waitlist period). Primary outcome measures will include adjustment disorder severity; secondary outcome measures will consist of other negative (psychopathology: depression, anxiety, and stress) and positive (life satisfaction) indexes of mental health as well as process measures (e.g. mindfulness, experiential avoidance, cognitive fusion). Discussion: To our knowledge, the current study is the first to evaluate the effectiveness of a psychological intervention for students with adjustment disorder. Therefore, it may have important practical implications for students with this disorder. It can potentially guide the development of a scalable, validated treatment option. Trial registration: Clinical Trials, NCT05768308, registered 14 March 2023, https://www.clinicaltrials.gov/ct2/show/NCT05768308

18 April 2025 in Healthcare
Verified
Journal Article
Open access
PHPawel Holas
Pawel Holas
AJAleksandra Juszczyk-Kalina
Aleksandra Juszczyk-Kalina
JWJan Wardęszkiewicz
Jan Wardęszkiewicz
JCJoseph Ciarrochi
Joseph Ciarrochi
SHSteven C. Hayes
Steven C. Hayes
Objectives: The COVID-19 pandemic has significantly impacted mental health worldwide. This study investigated the relationship between perceived COVID-19 threat and adjustment disorder (AjD) severity, examining self-compassion (SC) and experiential avoidance (EA) as potential moderators. Additionally, cluster analysis—a statistical method for grouping individuals based on similar psychological characteristics—was employed to identify distinct profiles of SC and EA and their associations with AjD, depression, and anxiety symptoms. Methods: A sample of 308 participants meeting AjD criteria completed measures assessing AjD severity (ADNM-20), depression (PHQ-9), anxiety (GAD-7), SC, EA, and perceived threat of COVID-19. Moderation analyses were performed using the PROCESS macro. Cluster analysis identified profiles based on SC and EA scores, with clusters compared on AjD, PHQ, and GAD symptom severity. Results: SC and EA moderated the relationship between perceived COVID-19 threat and AjD severity. Interestingly, individuals with high EA and low SC exhibited no significant association between perceived threat and AjD symptoms. Cluster analysis revealed four distinct profiles: (1) high SC and low EA, (2) average SC and EA, (3) low SC and low EA, and (4) low SC and high EA. Participants in the high SC/low EA cluster reported significantly lower levels of AjD, depression, and anxiety symptoms compared to those in the low SC/high EA cluster, who exhibited the highest symptom severity across all measures. Conclusions: Our findings suggest that individuals who relied on experiential avoidance and lacked self-compassion experienced less emotional distress related to pandemic-related worries, potentially shielding themselves from acute AjD symptoms. However, this strategy was associated with greater emotional distress, as those with high AE and SC exhibited more symptoms of AjD, depression, and anxiety. In contrast, individuals with low AE and high SC demonstrated significantly better psychological well-being.

23 May 2023 in Research Square
Verified
Preprint
Open access
PDF file
AJAleksandra Juszczyk-Kalina
Aleksandra Juszczyk-Kalina
PHPaweł Holas
Paweł Holas
TFTodd Farchione
Todd Farchione
Background Adjustment problems and disorders are highly prevalent among university students worldwide. Unfortunately, only half of students in need receive psychological help. Furthermore, there is a paucity of studies evaluating prevalence, predictors and interventions for adjustment disorders in students. For these reasons, new, more scalable forms of treatment for students with adjustment disorder must be developed, evaluated and implemented. The aim of the study is to determine the effectiveness of an online transdiagnostic cognitive behavioural intervention for students experiencing adjustment disorder and to evaluate mediators of change. Method/Design In this three-arm randomized controlled trial, we plan to recruit 214 Polish students diagnosed as having an adjustment disorder. Participants who meet initial eligibility criteria will be randomly assigned to one of three conditions: 1) 6-week online cognitive behavioural therapy intervention based on the Unified Protocol, 2) 6-week online progressive muscle relaxation training as an active control group, or 3) waiting-list control group. Both the internet and active interventions are asynchronous, unguided and interactive. Assessments will consist of self-report questionnaires, daily diary measures, neurocognitive tasks for the evaluation of cognitive functioning, and recently received grades at university. Measures will be taken at baseline, at post-treatment and at 1-month follow-up. Daily diary measures will be taken during the first and last week of the interventions. Primary outcome measures will include adjustment disorder severity; secondary outcome measures will include other negative (psychopathology: depression, anxiety and stress) and positive (life satisfaction and level of academic adjustment) indexes of mental health as well as and process measures (e.g., mindfulness, experiential avoidance, cognitive fusion). Discussion The current study, to our knowledge, is to be the first evaluating the effectiveness of a psychological intervention for students with adjustment disorder. Therefore, it may have important practical implications for students with this disorder. It has the potential to guide the development of a scalable, validated treatment option. Trial registration Clinical Trials, NCT05768308, registered 14 March 2023, https://www.clinicaltrials.gov/ct2/show/NCT05768308